Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

<strong>Background:</strong> Blood biomarkers may aid in recruitment to clinical trials of Alzheimer’s disease (AD) modifying therapeutics by triaging potential trials participants for amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) Aβ and tau tests. <strong&g...

書誌詳細
主要な著者:	Westwood, S, Baird, AL, Hye, A, Ashton, NJ, Nevado-Holgado, AJ, Anand, SN, Liu, B, Newby, D, Bazenet, C, Kiddle, SJ, Ward, M, Newton, B, Desai, K, Hehir, C, Zanette, M, Galimberti, D, Parnetti, L, Lleó, A, Baker, S, Narayan, VA, Van Der Flier, WM, Scheltens, P, Teunissen, CE, Visser, PJ, Lovestone, S
フォーマット:	Journal article
出版事項:	Frontiers Media 2018

類似資料

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
著者:: Sarah Westwood, 等
出版事項: (2018-12-01)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
著者:: Westwood, S, 等
出版事項: (2017)

New CSF biomarkers on the block
著者:: Charlotte E Teunissen, 等
出版事項: (2016-09-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
著者:: Rosha Babapour Mofrad, 等
出版事項: (2019-12-01)

Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
著者:: Nevado-Holgado, A, 等
出版事項: (2016)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
著者:: Eleonora M. Vromen, 等
出版事項: (2022-01-01)

Blood-based proteomic biomarkers of Alzheimer’s disease pathology
著者:: Baird, A, 等
出版事項: (2015)

Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
著者:: Alejo J Nevado-Holgado, 等
出版事項: (2017-01-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
著者:: Betty Marije Tijms, 等
出版事項: (2021-08-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
著者:: Yong-Jin Park, 等
出版事項: (2025-01-01)

Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques
著者:: Sanna Hellberg, 等
出版事項: (2019-03-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
著者:: Teunissen, C, 等
出版事項: (2018)

Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
著者:: Lyduine E. Collij, 等
出版事項: (2023-11-01)

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
著者:: Si Eun Kim, 等
出版事項: (2020-01-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
著者:: Eline A. J. Willemse, 等
出版事項: (2021-01-01)

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.
著者:: Stephanie J B Vos, 等
出版事項: (2014-01-01)

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study
著者:: Yanaika S. Hok‐A‐Hin, 等
出版事項: (2023-07-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease
著者:: Winchester, L, 等
出版事項: (2018)

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
著者:: Mark R. Battle, 等
出版事項: (2018-12-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
著者:: Charlotte E. Teunissen, 等
出版事項: (2018-03-01)

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
著者:: Vandenberghe, R, 等
出版事項: (2013)

Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated
著者:: Young-Sil An, 等
出版事項: (2021-06-01)

Temporal and anatomical distribution of 18F-flutemetamol uptake in canine brain using positron emission tomography
著者:: Taesik Yun, 等
出版事項: (2020-01-01)

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
著者:: Juhan Reimand, 等
出版事項: (2019-12-01)

Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly
著者:: Westwood, S, 等
出版事項: (2016)

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
著者:: Vandenberghe, R, 等
出版事項: (2010)

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
著者:: Hugh G. Pemberton, 等
出版事項: (2023-05-01)

Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning
著者:: Chan Ju Ryu
出版事項: (2022-12-01)

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
著者:: Fiona Heeman, 等
出版事項: (2019-03-01)

Cross-sectional and longitudinal analyses of outdoor air pollution exposure and cognitive function in UK Biobank
著者:: Cullen, B, 等
出版事項: (2018)

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank
著者:: Nevado-Holgado, A, 等
出版事項: (2016)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
著者:: Winchester, L, 等
出版事項: (2022)

18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease：a preliminary study
著者:: LEI Zhe, 等
出版事項: (2022-07-01)

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
著者:: Milos D. Ikonomovic, 等
出版事項: (2018-06-01)

Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
著者:: Hiroshi Matsuda, 等
出版事項: (2021-01-01)

Blood based proteomic biomarkers of Alzheimer’s disease pathology
著者:: Alison Louise Baird, 等
出版事項: (2015-11-01)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
著者:: Carla M. Startin, 等
出版事項: (2019-03-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease
著者:: Laura M. Winchester, 等
出版事項: (2018-06-01)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
著者:: Wesenhagen, KEJ, 等
出版事項: (2025)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
著者:: Kirsten E. J. Wesenhagen, 等
出版事項: (2025-03-01)